RTW Biotech portfolio company Yarrow Bioscience completes merger
Lupin's Diazepam Injection, USP receives US approval
Auxilium Health changes name to Aeris Biosciences
Saol Therapeutics' SL1009 (DCA) resubmission accepted by FDA
Lantern Pharma advances EMA-cleared Phase 1b/2 bladder cancer trial for LP-184
AcuCort secures renewed FDA fee waiver ahead of planned NDA submission
Yarrow Bioscience completes VYNE merger and begins Phase 2 trial of YB-101